- Estimates predict in 2010, the counterfeit market will reach 75 billion dollars: a 90% hike from 2005 for a total comparable to that of illegal drug trafficking.
- In some countries, counterfeit medication reaches over 30% of all medication for sale
The sale of untested, dangerous or inactive medication represents a threat to public health, as well as a moral scandal, and a challenge for those involved in development.
This is why the Fondation Chirac has decided to participate alongside the authorities of Benin and the Fondation Pierre Fabre to consolidate policies concerning access to quality medicine in West Africa. We support the extension of the National Quality Control Laboratory for Medicine in Benin (Photo opposite: the Laboratory team surrounding its Director, M.Baba-Moussa, and Philippe Bernagou, General director of the Fondation Pierre Fabre – photo credits: LNCQ).
This extension will add another floor to the current building, allowing the laboratory to house three new analysis units. Work starts in February.
Valérie Terranova, founding member and Council Secretary of the Administrative Board of the Fondation Chirac, and Philippe Bernagou, General Director of the Fondation Pierre Fabre, will go to Cotonou from February 22 to 26 to sign the partnership Convention with Benin’s authorities and lay the founding stone.
With its different partners, the Fondation Chirac actively participates in a mobilization program against counterfeit drugs. The extension of the National Quality Control Laboratory for Medicine is a first step.